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Purpose.The increased use ofmagnetic resonance imaging (MRI) has resulted in reports of incidental abnormal bonemarrow (BM)
signal. Our goal was to determine the evaluation of an incidental abnormal BM signal on MRI and the prevalence of a subsequent
oncologic diagnosis. Methods. We conducted a retrospective cohort study of patients over age 18 undergoing MRI between May
2005 and October 2010 at Tufts Medical Center (TMC) with follow-up through November 2013.The electronic medical record was
queried to determine imaging site, reason for scan, evaluation following radiology report, and final diagnosis. Results. 49,678 MRIs
were donewith 110 patientsmeeting inclusion criteria. Twenty two percent underwent some evaluation,most commonly a complete
blood count, serum protein electrophoresis, or bone scan.Withmedian follow-up of 41months, 6% of patients were diagnosed with
malignancies includingmultiple myeloma, non-Hodgkins lymphoma, metastatic non-small cell lung cancer, andmetastatic adeno-
carcinoma. One patient who had not undergone evaluation developed breast cancer 24months after theMRI.Conclusions. Inciden-
tally noted abnormal or heterogeneous bonemarrow signal onMRIwas not inconsequential and should prompt further evaluation.
1. Introduction
Red to yellow bone marrow conversion occurs predictably
with aging, with fatty replacement of cellular hematopoieti-
cally active marrow starting in the peripheral appendicular
skeleton and proceeding to the central axial skeleton [1–
3]. Reconversion to hematopoietically active marrow can
occur in the setting of malignancy, necrosis, fibrosis, edema
secondary to trauma or stress, replacement, infiltration, or
infection, but the patient may be asymptomatic clinically [3,
4]. In addition, heavy smoking history has been significantly
associatedwithmarrow reconversion [5].While reconversion
can be seen noninvasively on MRI, the exact etiology is
difficult to determine from imaging alone.
Over the past two decades, the use of magnetic resonance
imaging (MRI) has increased annually [6], resulting in
increased numbers of incidental findings [7–9]. The few
studies that have examined the etiology of these findings
found primarily benign lesions and rarely occult systemic
malignancy [10–13]. Abnormal bone marrow (BM) signal is
one such incidental finding and often prompts consult to
hematology/oncology for evaluation of primary BM disor-
ders. The prevalence of malignant diagnoses in such cases is
unknown.
The purpose of our retrospective study of adult patients
evaluated with MRI at Tufts Medical Center (TMC) was to
determine the prevalence of a subsequent oncologic diagnosis
and the appropriate evaluation for such findings as there is no
standard in the published literature.
2. Methods
Between May 9, 2005 and October 31, 2010, the TMC
Department of Radiology picture archiving and commu-
nication system (PACS) reports were searchable using GE
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Centricity Radiology Information System 2.2. Potential cases
were identified by searching for MRI reports containing the
phrases “abnormal bone marrow” or “heterogeneous bone
marrow” during this time frame in patients over 18 years of
age.
Cases in which the radiologist commented that there was
no abnormal bone marrow signal or in which the patient
had an underlying malignant diagnosis were excluded. Cases
that remained for analysis either had no clear etiology of the
abnormal signal stated in the report or clinical correlation
was suggested by the radiologist. Patients undergoingMRIs of
multiple anatomic sites on the same day prompting duplicate
reports were included only once.
This study was performed with approval from the TMC
Institutional Review Board and analyzed using Excel 2010
(Microsoft, Redmond, WA).
Demographics were collected from the electronic med-
ical record (EMR). In addition, the ordering specialty, the
anatomic location of the MRI, and the reason for the scan
were abstracted from the radiology report. Reasons for the
scan were combined into related categories. Musculoskeletal
complaints included fractures and pain, including neck,
shoulder, elbow, back, hip, knee, leg, or foot pain. Neurologic
complaints included headaches, cerebrovascular accidents,
transient ischemic attacks, multiple sclerosis, middle cerebral
artery aneurysms, arm numbness and weakness, neurogenic
claudication, leg weakness, radiculopathy, myelopathy, spinal
stenosis, and paresthesias. Osteomyelitis, abscesses, and
tuberculosis were categorized as infection. Prior abnormal
imaging included scans done after findings on computed
tomography scans and X-rays. Another category was created
for the remainder of reasons, including axilla pain, pelvic
pain, osteoporosis, hematuria, fibroids, evaluations for sus-
pected pheochromocytomas and prolactinomas, soft tissue
masses, and fibroids.
Further evaluation was defined as any referral to a
subspecialist, laboratory test, imaging study, or procedure
mentioned as part of an evaluation for this finding in
an outpatient clinic note or inpatient discharge summary
included in the TMC EMR after the incident MRI. Final
diagnosis was defined by a pathology report confirming the
diagnosis or a physician documenting the etiology of the
abnormal signal. Time to hematology/oncology referral and
time to final diagnosis were calculated from the date of the
MRI. If nowork-upwas done or no diagnosis was determined
in those patients undergoing evaluation, the medical record
was examined for later diagnosis of amalignancy. Last follow-
up was documented as of November 15, 2013.
Smoking status and hemoglobin less than 12mg/dL doc-
umented within three months of the MRI were also collected
to account for other differential diagnoses.
3. Results
3.1. Cohort Characteristics. Between May 2005 and October
2010, 49,678 MRIs were performed at Tufts Medical Center
with 110 patients (pts) meeting search criteria (Figure 1), 47
men and 63women.Median agewas 58.5 years (range, 20–89)
MRI report with bone 
marrow evaluated 
Excluded: 
No mention of bone 
marrow in report
Excluded: 
No abnormal signal
Abnormal signal with 
history of cancer MRI reports in patients 
with abnormal MRI signal 
and no history of cancer 
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Duplicate reports for 
multiple scans on same day 
for same patient.
Analyzed patients 
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(n = 110)
(n = 64)
(n = 12,482)
Figure 1: Flow diagram of study.
with amedian follow-up at TMCof 41months after qualifying
MRI (range, 0–103).Thirteen percent had less than 1month of
follow-up.The majority of patients underwent an MRI of the
lumbar spine (43%), hip (13%), or knee (7%) (Figure 2), with
most of the scans done for musculoskeletal and neurologic
complaints (Table 1). Primary care (internal medicine and
family practice) was the most common ordering specialty
(42%), followed by orthopedics (12%), and neurology (11%).
A large portion of the patients were never smokers at the time
of the MRI (47%), while only 21% had a hemoglobin of less
than 12mg/dL within 3 months of the scan (Table 1).
3.2. Evaluation. Twenty four patients (22%) underwent
further work-up. Laboratory evaluation included complete
blood count (11 pts, 46%), serum protein electrophoresis
(7 pts, 29%), quantitative immunoglobulins (4 pts, 17%), and
serum free light chains (3 pts, 13%). Further imaging included
bone scan (11 pts, 46%), CT scan (7 pts, 24%), skeletal survey
(4 pts, 17%), repeat MRI (4 pts, 17%), and DEXA scan (1 pt,
4%). Bone marrow biopsies were done in 17% (4 pts) of
those evaluated, while other sites were biopsied in 24%
(6 pts) of patients. Subspecialty referrals were made for 16 pts
(42%), with 6 (25%) to hematology/oncology, 3 (13%) to
neurosurgery, and 1 (4%) to orthopedics (Figure 3). Referral
to the surgical specialties prompted follow-up imaging, but
no additional laboratory testing. All patients referred to
hematology/oncology had abnormal lumbar spine MRIs. In
patients who had an abnormal scan but did not undergo any
evaluation, 31 (36%) were current or former smokers at the
time of the MRI and 23 (20%) had hemoglobin less than
12mg/dL within 3 months of the scan.
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Figure 2: Number of abnormal MRI scans by anatomic location.
3.3. Definitive Diagnosis. A definitive diagnosis was assigned
in 11/24 (46%) cases that were evaluated and in none of those
that did not undergo work-up. Nonmalignant diagnoses
included hemangiomas (3/24), osteoporosis (1/24), and bone
bruising (1/24). Malignant diagnoses were identified in 6/24
(25%) patients with 3 patients having multiple myeloma
(MM), one mucosa-associated lymphoid tissue (MALT)
lymphoma, one metastatic non-small cell lung cancer, and
one metastatic adenocarcinoma. One patient who did not
undergo any evaluation was later diagnosed with breast
cancer at 24 months post scan, resulting in a 7/110 (6%)
incidence ofmalignancy among patients with abnormal bone
marrow signal reported on MRI.
4. Discussion
Increased demand for hematopoiesis prompts reconversion
from fattymarrow to cellularly active redmarrow.Thepattern
occurs opposite to the initial conversion beginning in the
pelvis and proceeding peripherally to the long bones [14]
and is evident noninvasively on MRI scans. As the skeleton
is imaged on scans of many anatomical sites, this incidental
findingmay be the initial sign of an underlyingmalignancy in
an otherwise asymptomatic patient undergoing imaging for
another complaint.
This is the first study to evaluate the incidence and evalu-
ation of abnormal bone marrow signals seen incidentally on
MRI. Other studies have examined more global incidental
findings on MRIs of specific anatomic areas. High rates of
incidental findings have been found on brainMRIs including
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Figure 3: Percentage of evaluated patients (𝑁 = 110) undergoing
each test. Red bars indicate hematology/oncology referral and
subsequent testing by hematology/oncology. Numbers on the bars
are the actual numbers of patients evaluated with each test.
0.7–1.6% benign and malignant tumors [15, 16]. Similarly,
extraintestinal findings were seen in 25–57% of patients on
abdominal MRIs with 0.7% resulting in a cancer diagnosis
[13, 17] and clinically significant incidental findings were seen
on 10–34% of cardiac MRIs, with malignant diagnoses found
in 0.4–4.8% including lung cancers, lymphoma, and thyroid
cancer [12, 18, 19]. Furthermore, 10–32% of whole body
MRIs had clinically relevant abnormalities requiring work-
up with 5.9% identifying a malignancy [10, 20]. Interestingly,
abnormal bone marrow signal was not mentioned. In our
study, the overall rate of bone marrow signal abnormalities
in all patients undergoing MRI was low, but six percent of
patients meeting our criteria were subsequently diagnosed
with a malignancy.
The lumbar spine was the most commonly imaged site
in which an abnormal bone marrow signal was noted. This
is likely due to the expected pattern of reconversion starting
centrally. Our rates were similar to a study of lumbar spine
MRIs which reported that 3.2% of patients were diagnosed
with a pathologically confirmed incidental malignancy, with
four patients having bladder cell transitional carcinoma, two
colorectal cancers, and one prostate cancer extending to the
bladder [9]. However, our study had amore even distribution
of hematologic malignancies and solid tumors.
Differentiation between malignancies by imaging can be
difficult. Hypercellular marrows such as those caused by
myeloproliferative diseases and leukemias can range from
patchy heterogeneity to diffuse replacement, while cellular
depletion states such as aplastic anemia show increased signal
intensity on T1-weighted images [21]. Delorme et al. have
shown that MM can have focal lesions, homogeneous diffuse
infiltration, mixed diffuse and focal infiltration, a variegated
salt-and-pepper pattern with scattered fatty islands, or a
normal pattern on MRI [22–24]. Marrow infiltration by
lymphoma or metastatic solid tumors replaces the fatty
marrow with malignant cells and is evidenced on imaging by
focal decreases in T1-weighted series. Scans of patients with
nonmalignant hematologic diagnoses such as thalassemia
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Table 1: Cohort characteristics.
All patients
𝑛 = 110, (%)
Evaluated
𝑛 = 24, (%)
Not evaluated
𝑛 = 86, (%)
Age, median (range), and years 58.5 (20–89) 58.5 (24–83) 59 (20–89)
Male gender 47 (43) 8 (33) 39 (45)
Follow-up, median, and months 41 (0–103) 42.7 (0.3–96) 39.6 (0–103)
MRI location
Lumbar spine 46 (42) 12 (50) 34 (40)
Hip 14 (13) 2 (8) 12 (14)
Cervical spine 10 (9) 3 (13) 7 (8)
Knee 8 (7) 1 (4) 7 (8)
Reason for scan
Musculoskeletal complaint 67 (61) 13 (54) 54 (63)
Neurologic complaint 26 (24) 7 (29) 19 (22)
Infection 4 (4) 0 (0) 4 (5)
Prior abnormal imaging 3 (3) 1 (4) 2 (2)
Other 9 (8) 3 (13) 6 (8)
Ordering specialty
Internal medicine 42 (38) 8 (33) 34 (40)
Orthopedics 13 (12) 2 (8) 11 (13)
Neurology 12 (11) 3 (13) 9 (10)
Other 43 (39) 11 (46) 32 (37)
Smoking
Current smoker at scan 20 (18) 4 (17) 16 (19)
Former smoker at scan 19 (17) 4 (17) 15 (17)
Never smoker 52 (47) 15 (63) 37 (43)
Unknown 19 (17) 1 (4) 18 (21)
Hemoglobin within 3 months of scan
mgdL 23 (21) 6 (25) 17 (20)
mgdL 46 (42) 11 (46) 35 (41)
Unknown 41 (37) 7 (29) 34 (39)
and sickle cell disease often show diffuse symmetric recon-
version and changes in marrow signal due to iron deposition
[11].
Referral to neurosurgery and orthopedics primarily
involved evaluation of imaging as opposed to ordering of
additional testing. Hematology/oncology referral prompted
laboratory and imaging evaluation predominantly for the
purposes of identifying MM. As three of the six patients
with identified malignant diagnoses had MM, such work-
up may not be unreasonable. Three patients were diagnosed
with lymphoma and metastatic solid tumors and evaluation
of imaging for the patterns described above may help to
determine the location to biopsy for greatest diagnostic yield.
Hemangiomas were the most common nonmalignant
final diagnosis in our study. Park et al. evaluated the fre-
quency of incidental findings on lumbar spine MRIs and
found hemangiomas accounted for 1.5% of the cases [7].
While we found a higher percentage in those undergoing
evaluation, the number of hemangiomas overall was similar
to the frequency at autopsy [25]. These thin-walled blood
vessels formdilated vasculature causing a distinctivemottling
of the vertebral bodies and increased signal on both T1- and
T2-weighted images [7, 26].
Hip and knee imaging accounted for 20% of the scans
with abnormal bone marrow signals. Several studies have
assessed the association between pain and bone marrow
lesions (BML) over time. These studies found that the size of
the BML correlates with pain, though the evidence is stronger
for hip than knee. In addition, the lesions changed over time
corresponding to pain level and need for surgery [4, 27]. In
our study, the majority of scans were done as an evaluation
for pain, but there was nomention of following the lesions by
the ordering physician.
Other states of reduced oxygen carrying capacity and
hypoxia can prompt an increase in marrow reconversion.
Examples of such states include high altitude settings, obesity,
smoking [5], other pulmonary diseases, and athletes partic-
ipating in large oxygen debt sports such as long distance
running [28]. In addition, metabolism of fatty marrow for
energy production can occur in states of extreme cachexia
such as human immunodeficiency virus (HIV) infection,
chronic renal disease, and anorexia [21]. Questions about new
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activities, weight changes, or other health abnormalities may
point to the etiology if clinical suspicion ofmalignancy is low.
Several characteristics of the signal can help to differ-
entiate between malignant and nonmalignant reconversion.
Malignant etiologies often cause asymmetric reconversion
while nonmalignant reconversion ismore likely to be bilateral
and symmetric. In addition, neoplastic marrow enhances
morewith gadoliniumadministration and the signal intensity
on short TI inversion recovery (STIR) imaging is greater
than the signal intensity of muscle. Furthermore, metastatic
lesions tend to localize in the red marrow due to increased
blood supply [14]. In our study, we primarily focused on the
radiologist’s reports and therefore were unable to evaluate
the signal characteristics. Discussionwith the radiologistmay
narrow necessity of further testing based on radiographic
criteria.
Limitations of this study include follow-up limited to vis-
its at TMC. As TMC is a tertiary care center, several patients
were sent only for the MRI with no other encounters within
our system or only saw specialists and had their primary care
and possible evaluation elsewhere. Inclusion of all patients
may have biased the results towards infrequent work-up and
diagnosis. If those patients with less than one month of
follow-up are excluded, there is a 7/95 (7.4%) incidence of
malignancy in our series. Furthermore, it was not possible to
delineate what prompted further evaluation and, therefore, a
systemic issue we did not collectmay have had diagnostic sig-
nificance. As this was a retrospective study abstracting from
the EMR, it is unclear if these findings and possible work-up
were discussed with the patient and not documented.
Finally, we attempted to account for other nonmalignant
etiologies by evaluating the relationship between hemoglobin
and smoking at the time of the scan. However, other non-
malignant etiologies were difficult to determine from the
available records. Further studies may help to elucidate the
appropriate order of work-up.
In summary, incidentally noted abnormal or heteroge-
neous bone marrow signal on MRI was not inconsequential.
Of those patients who met our study criteria, 6% were
diagnosed with a malignancy. We conclude that abnormal
bone marrow findings on MRI should not be ignored and
initial evaluation by primary care physicians could include
identification of cancer risk and possibly laboratory evalua-
tion for multiple myeloma.
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